NCT04550741Completed
Long-term Maintenance Benefits of a Pulmonary Rehabilitation Program Using a Mobile Digital Solution: a Prospective, Randomized, Controlled, Multicenter Study in a Population of COPD Patients
Source: ClinicalTrials.gov · Last updated 30 Sept 2025
Brief summary (registry, in English)
Chronic obstructive pulmonary disease (COPD) is a public health problem: high prevalence; increasing morbidity and mortality; impact on health costs. Pulmonary rehabilitation (PR) is a multidisciplinary intervention combining exercise training, therapeutic education, psychosocial and behavioral interventions. Its effects are beneficial in the short and medium terms but are limited in time, between 6 and 12 months, for patients who do not pursue regular physical activity (PA) in post-rehabilitation and who do not adopt behavioral changes for health, by loss of motivation. Maintaining the long-term benefits acquired during a short-term PR program is therefore a major issue in the management of COPD. The recent development of remote rehabilitation is a promising approach that has been studied in few studies. In a randomized, controlled and multicenter study, we propose to test the hypothesis that the use of a mobile telerehabilitation solution will allow COPD patients to mainain at long-term the benefits acquired during a short-temr programm and therfore improve their quality of life. (PA) in post-rehabilitation and who do not adopt behavioral changes for health, by loss of motivation. Maintaining the long-term benefits acquired during a short-term PR program is therefore a major issue in the management of COPD. The recent development of remote rehabilitation is a promising approach that has been studied in few studies. In a randomized, controlled and multicenter study, we propose to test the hypothesis that the use of a mobile telerehabilitation solution will allow COPD patients to mainain at long-term the benefits acquired during a short-temr programm and therfore improve their quality of life.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 200 (actual)
- First submitted
- 29 Jun 2020
- Start date
- 10 Mar 2022
- Primary completion date
- 28 Nov 2024
- Lead sponsor
- University Hospital, Montpellier
- Diseases
- COPD
- NCT number
- NCT04550741
What you commit to
- Study type: Interventional
- Participants enrolled: 200
- From 10 Mar 2022 to the primary completion date, 28 Nov 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of contraindications for exercise training (neuromuscular disease, orthopedic cause).
- Patients with significant and unstable cardiovascular disease.
Other
- Inability to understand and/or answer questionnaires.
- Refusal to use a smartphone or digital device.
- Unable to access an internet connection at home.
Who the study is looking for
- Patients diagnosed with COPD according to the GOLD (Global Initiative for Chronic Obstructive Lung Disease) creteria.
- Presence of an incompletely reversible obstructive ventilatory disorder defined by a report VEMS / CVF lower than the lower limit of normal post-bronchodilator.
- Patient on RR for four weeks in respiratory rehabilitation center.
- Aged between 40 and 78 years.
Age in the registry: 40 years to 78 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre hopsitalier universitaire de Montpellier Coordinator of this site? Confirm its status | Montpellier | France | Unknown status |
| Clinique du Souffle Coordinator of this site? Confirm its status | Osséja | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.